Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Go back to Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
(NASDAQ: CADL) Delayed: 9.26 +0.95 (11.43%)
Previous Close $8.31    52 Week High
Open $8.41    52 Week Low
Day High $9.26    P/E N/A 
Day Low $8.39    EPS
Volume 1,197,428